STAT+: At MAHA Summit, a grassroots movement goes corporate
Federal officials and health care executives rubbed elbows at the ritzy MAHA Summit, causing some supporters to question what MAHA has become.
Martes 29 de septiembre de 2026 · 152 publicaciones en las últimas 24 h · 29 fuentes · actualizado hace 20 min
Periodismo sobre salud, medicina y ciencias de la vida. Prensa médica · Estados Unidos · Sitio oficial.
20 notas · Solo en español
Federal officials and health care executives rubbed elbows at the ritzy MAHA Summit, causing some supporters to question what MAHA has become.
Some lawmakers are urging the Trump administration to rethink a pending rule that may prevent Americans from obtaining medicines from licensed international pharmacies.
Eric Cantor, a former GOP House majority leader, is taking the helm of PhRMA at a challenging time for the industry.
The gene-editing company Beam Therapeutics is alleging that one of its scientists stole intellectual property and used it to co-found a Chinese company that made a deal with VC firms.
Health department nominees await Senate votes, and we map out what the elections mean for healthy policy.
In this edition of STAT Health Tech: Oura delays IPO plans, Anthropic joins an clinical AI effort by ARPA-H, and MAHA's health data goals.
AstraZeneca is teaming up with Summit Therapeutics to test its PD-1/VEGF bispecific ivonescimab alongside AstraZeneca’s antibody-drug conjugates.
Novo has agreed to pay up to $2.6 billion to license an experimental, weekly weight loss pill from China’s Hengrui Pharma
A new study in mice led by Washington University in St. Louis researchers suggests that stopping certain immune cells from entering the brain could limit neurodegeneration.
UniQure's gene therapy continues to slow Huntington's progression after four years. But the magnitude of the benefit waned compared to a similar analysis from a year ago.
At a MAHA Institute event, Kennedy and others argued that health data should be more accessible to researchers can study vaccines, chronic diseases, and autism
Jennifer Reich has spent two decades speaking to families about their immunization decisions. In an interview, she unpacks what she's learned.
New medical devices deemed "breakthrough" by the FDA are no longer automatically eligible for extra Medicare payments.
Big shifts in health care policy could emerge depending on who wins the midterms, affecting hospitals and pharma companies.
“National security begins in childhood,” write Tina L. Cheng, Stanley McChrystal, and James M. Perrin.
"We should not make families poorer and then punish them for their poverty," write Sandy Santana and Kristen Weber of the National Center for Youth Law.
Post-wildfire air quality needs to be monitored long term, suggests a study finding Maui residents had high levels of toxic metals months later.
Merck discontinued Recarbio, an important antibiotic in the U.S., despite concerns over resistance to superbugs.
The Trump administration asked the Supreme Court on Monday to let it enforce, for now, restrictions on gender-affirming care in federal prison.
Health insurance premiums are skyrocketing, private equity hospital chain goes nonprofit, and more from STAT's Health Care Inc.
Mostramos el titular, un extracto breve y el enlace a cada nota; el contenido completo y sus derechos son de cada medio. Las notas se recogen automáticamente de los canales RSS públicos de las fuentes cada 30 minutos y se clasifican por especialidad con palabras clave, así que alguna puede quedar en una sección que no le corresponde. Una noticia no es una recomendación clínica: antes de cambiar una conducta, revisa el artículo original y las guías vigentes. ¿Eres editor de un medio y prefieres no aparecer? Escríbenos. Suscríbete por RSS.